Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translationShow others and affiliations
2022 (English)In: FEBS Letters, ISSN 0014-5793, E-ISSN 1873-3468, Vol. 596, no 9, p. 1203-1213Article in journal (Refereed) Published
Abstract [en]
Nonstructural protein 1 (Nsp1) of SARS-CoV-2 inhibits host cell translation through an interaction between its C-terminal domain and the 40S ribosome. The N-terminal domain (NTD) of Nsp1 is a target of recurring deletions, some of which are associated with altered COVID-19 disease progression. Here, we characterize the efficiency of translational inhibition by clinically observed Nsp1 deletion variants. We show that a frequent deletion of residues 79–89 severely reduces the ability of Nsp1 to inhibit translation while not abrogating Nsp1 binding to the 40S. Notably, while the SARS-CoV-2 5′ untranslated region enhances translation of mRNA, it does not protect from Nsp1-mediated inhibition. Finally, thermal stability measurements and structure predictions reveal a correlation between stability of the NTD and the efficiency of translation inhibition.
Place, publisher, year, edition, pages
John Wiley & Sons, 2022. Vol. 596, no 9, p. 1203-1213
Keywords [en]
COVID-19, Nsp1, pathogenicity, ribosome, SARS-CoV-2, virus
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) Infectious Medicine Biochemistry Molecular Biology
Identifiers
URN: urn:nbn:se:umu:diva-194639DOI: 10.1002/1873-3468.14354ISI: 000786558400001PubMedID: 35434785Scopus ID: 2-s2.0-85129091882OAI: oai:DiVA.org:umu-194639DiVA, id: diva2:1658132
Funder
Swedish Cancer Society, 20 0872 PjThe Kempe Foundations, JCK-1723.2Knut and Alice Wallenberg Foundation, 2020.0037Swedish Research Council, 2017-03783Swedish Research Council, 2021-011462022-05-132022-05-132025-02-20Bibliographically approved